{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:15:26Z","timestamp":1753892126009,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> We previously reported that malignant hypertension is associated with impaired capillary density of target organs. Here, we tested the hypothesis that stabilization of hypoxia-inducible factor (HIF) in a modified \u201cpreconditioning\u201d approach prevents the development of malignant hypertension. To stabilize HIF, we employed pharmacological inhibition of HIF prolyl hydroxylases (PHD), that profoundly affect HIF metabolism.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Two-kidney, one-clip renovascular hypertension (2K1C) was induced in rats; controls were sham operated. 2K1C rats received either intermittent injections of the PHD inhibitor ICA (2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido) acetate) or placebo. Thirty-five days after clipping, the frequency of malignant hypertension was assessed (based on weight loss and the occurrence of characteristic vascular lesions). In addition, kidney injury was compared between all ICA treated versus all placebo treated 2K1C, regardless of the occurrence of malignant hypertension. HIF stabilization was evaluated by immunohistochemistry, and HIF target gene expression by RT-PCR.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Blood pressure was elevated to the same degree in ICA- and placebo-treated 2K1C compared to control rats. ICA treatment did not affect the frequency of malignant hypertension or the extent of kidney tissue fibrosis, inflammation, or capillary density. There was a trend towards higher mortality and worse kidney function in ICA-treated 2K1C rats. ICA increased the number of HIF-1\u03b1-positive renal tubular cell nuclei and induced several HIF-1 target genes. In contrast, expression of HIF-2\u03b1 protein as well as HIF-2 target genes were markedly enhanced by 2K1C hypertension, irrespective of ICA treatment.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> We conclude that intermittent PHD inhibition did not ameliorate severe renovascular hypertension in rats. We speculate that the unexpected strong renal accumulation of HIF-2\u03b1 in renovascular hypertension, which could not be further augmented by ICA, may contribute to the lack of a benefit from PHD inhibition.<\/jats:p>","DOI":"10.3389\/fphys.2023.1208105","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T12:08:56Z","timestamp":1687781336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats"],"prefix":"10.3389","volume":"14","author":[{"given":"Andrea","family":"Hartner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Dambietz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Cordasic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Willam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolai","family":"Burzlaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Br\u00f6tsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Veelken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Schley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl F.","family":"Hilgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/sj.ki.5000062","article-title":"Expression of hypoxia-inducible transcription factors in developing human and rat kidneys","volume":"69","author":"Bernhardt","year":"2006","journal-title":"Kidney Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1161\/CIRCRESAHA.117.305109","article-title":"HIF hydroxylase pathways in cardiovascular physiology and medicine","volume":"117","author":"Bishop","year":"2015","journal-title":"Circ. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"9806","DOI":"10.1002\/jcp.29794","article-title":"Adjunctive mesenchymal stem\/stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy","volume":"235","author":"Chen","year":"2020","journal-title":"J. Cell Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1097\/HJH.0b013e32836356a0","article-title":"Inhibition of prolyl hydroxylase domain-containing protein on hypertension\/renal injury induced by high salt diet and nitric oxide withdrawal","volume":"31","author":"Dallatu","year":"2013","journal-title":"J. Hypertens."},{"key":"B5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4172\/2167-1095.1000184","article-title":"The role of hypoxia-inducible factor\/prolyl hydroxylation pathway in deoxycorticosterone acetate\/salt hypertension in the rat","volume":"3","author":"Dallatu","year":"2014","journal-title":"J. Hypertens. (Los Angel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41371-019-0267-y","article-title":"Malignant hypertension: Does this still exist?","volume":"34","author":"Domek","year":"2020","journal-title":"J. Hum. Hypertens."},{"key":"B7","doi-asserted-by":"publisher","first-page":"H1877","DOI":"10.1152\/ajpheart.1992.262.6.H1877","article-title":"Effects of chronic hypoxia on capillary flow and hematocrit in rat skeletal muscle","volume":"262","author":"Fisher","year":"1992","journal-title":"Am. J. Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/01.asn.0000059308.82322.4f","article-title":"Podocyte expression of hypoxia-inducible factor (HIF)-1 and HIF-2 during glomerular development","volume":"14","author":"Freeburg","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fphys.2016.00370","article-title":"Impaired neovascularization and reduced capillary supply in the malignant vs. Non-malignant course of experimental renovascular hypertension","volume":"7","author":"Hartner","year":"2016","journal-title":"Front. Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/MNH.0000000000000431","article-title":"Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease","volume":"27","author":"Hasegawa","year":"2018","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1161\/hc3601.095576","article-title":"Angiotensin II type 1 receptor blockade prevents lethal malignant hypertension: Relation to kidney inflammation","volume":"104","author":"Hilgers","year":"2001","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.118.036157","article-title":"Endothelial hypoxia-inducible factor-2\u03b1 is required for the maintenance of airway microvasculature","volume":"139","author":"Jiang","year":"2019","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1128\/MCB.01055-15","article-title":"The endothelial prolyl-4-hydroxylase domain 2\/hypoxia-inducible factor 2 Axis regulates pulmonary artery pressure in mice","volume":"36","author":"Kapitsinou","year":"2016","journal-title":"Mol. Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1124\/jpet.119.262782","article-title":"DMOG, a prolyl hydroxylase inhibitor, increases hemoglobin levels without exacerbating hypertension and renal injury in salt-sensitive hypertensive rats","volume":"372","author":"Kato","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/HJH.0000000000000060","article-title":"Stabilization of hypoxia inducible factor-1\u03b1 ameliorates acute renal neurogenic hypertension","volume":"32","author":"Koeners","year":"2014","journal-title":"J. Hypertens."},{"key":"B16","doi-asserted-by":"publisher","first-page":"11351","DOI":"10.1038\/s41598-017-11829-2","article-title":"Selective tubular activation of hypoxia-inducible factor-2\u03b1 has dual effects on renal fibrosis","volume":"7","author":"Kong","year":"2017","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3233\/CH-190559","article-title":"Ciclopirox olamine promotes the angiogenic response of endothelial cells and mesenchymal stem cells","volume":"73","author":"Kremer","year":"2019","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/CIRCRESAHA.107.169201","article-title":"Salt-sensitive hypertension induced by decoy of transcription factor hypoxia-inducible factor-1alpha in the renal medulla","volume":"102","author":"Li","year":"2008","journal-title":"Circ. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/HYPERTENSIONAHA.115.05578","article-title":"Elevated endothelial hypoxia-inducible factor-1\u03b1 contributes to glomerular injury and promotes hypertensive chronic kidney disease","volume":"66","author":"Luo","year":"2015","journal-title":"Hypertension"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1681\/ASN.2016090960","article-title":"Endothelial Epas1 deficiency is sufficient to promote parietal epithelial cell activation and FSGS in experimental hypertension","volume":"28","author":"Luque","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/01.hyp.25.4.674","article-title":"Expression of angiotensin-converting enzyme in renovascular hypertensive rat kidney","volume":"25","author":"Mai","year":"1995","journal-title":"Hypertension"},{"key":"B22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1161\/HYPERTENSIONAHA.110.167106","article-title":"Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor","volume":"58","author":"Matsuura","year":"2011","journal-title":"Hypertension"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/ndt\/gfs517","article-title":"Intrauterine growth restriction leads to a dysregulation of Wilms' tumour supressor gene 1 (WT1) and to early podocyte alterations","volume":"28","author":"Menendez-Castro","year":"2013","journal-title":"Nephrol. Dial. Transpl."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1038\/s41598-018-22733-8","article-title":"Neonatal nephron loss during active nephrogenesis - detrimental impact with long-term renal consequences","volume":"8","author":"Menendez-Castro","year":"2018","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ki.2009.460","article-title":"Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization","volume":"77","author":"Paliege","year":"2010","journal-title":"Kidney Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"8386","DOI":"10.1073\/pnas.140087397","article-title":"The transcription factor EPAS-1\/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling","volume":"97","author":"Peng","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1113\/EP086734","article-title":"Previous exposure to chronic intermittent hypoxia blunts the development of one-kidney, one-clip hypertension in rats","volume":"103","author":"Perim","year":"2018","journal-title":"Exp. Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1681\/ASN.2004121051","article-title":"Hypoxia increases group IIA phospholipase A(2) expression under inflammatory conditions in rat renal mesangial cells","volume":"16","author":"Petry","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"F1265","DOI":"10.1152\/ajprenal.00260.2019","article-title":"Hypoxia-inducible factor-prolyl hydroxylase inhibitor ameliorates myopathy in a mouse model of chronic kidney disease","volume":"317","author":"Qian","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10557-021-07257-0","article-title":"Prolyl hydroxylase inhibitors: A new opportunity in renal and myocardial protection","volume":"36","author":"Requena-Ibanez","year":"2022","journal-title":"Cardiovasc Drugs Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1097\/01.asn.0000017223.49823.2a","article-title":"Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys","volume":"13","author":"Rosenberger","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1681\/ASN.2017020151","article-title":"Autologous mesenchymal stem cells increase cortical perfusion in renovascular disease","volume":"28","author":"Saad","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13287-016-0389-x","article-title":"Adipose-derived mesenchymal stem cells from patients with atherosclerotic renovascular disease have increased DNA damage and reduced angiogenesis that can be modified by hypoxia","volume":"7","author":"Saad","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.kint.2016.09.028","article-title":"Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease","volume":"91","author":"Schellinger","year":"2017","journal-title":"Kidney Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e31034","DOI":"10.1371\/journal.pone.0031034","article-title":"Renal tubular HIF-2\u03b1 expression requires VHL inactivation and causes fibrosis and cysts","volume":"7","author":"Schietke","year":"2012","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.kint.2019.02.016","article-title":"Mononuclear phagocytes orchestrate prolyl hydroxylase inhibition-mediated renoprotection in chronic tubulointerstitial nephritis","volume":"96","author":"Schley","year":"2019","journal-title":"Kidney Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.ajpath.2012.07.010","article-title":"Selective stabilization of HIF-1\u03b1 in renal tubular cells by 2-oxoglutarate analogues","volume":"181","author":"Schley","year":"2012","journal-title":"Am. J. Pathol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41581-019-0182-z","article-title":"Mechanisms of hypoxia signalling: New implications for nephrology","volume":"15","author":"Schodel","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3109\/15376516.2012.673088","article-title":"HIF-prolyl hydroxylases and cardiovascular diseases","volume":"22","author":"Sen Banerjee","year":"2012","journal-title":"Toxicol. Mech. Methods"},{"key":"B41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/CIRCRESAHA.108.182758","article-title":"Chronic hypoxia-induced angiogenesis normalizes blood pressure in spontaneously hypertensive rats","volume":"103","author":"Vilar","year":"2008","journal-title":"Circ. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"F1236","DOI":"10.1152\/ajprenal.00673.2013","article-title":"Silencing of hypoxia-inducible factor-1\u03b1 gene attenuates chronic ischemic renal injury in two-kidney, one-clip rats","volume":"306","author":"Wang","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/HYPERTENSIONAHA.109.145896","article-title":"Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla","volume":"55","author":"Wang","year":"2010","journal-title":"Hypertension"},{"key":"B44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1096\/fj.02-0445fje","article-title":"Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs","volume":"17","author":"Wiesener","year":"2003","journal-title":"FASEB J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e133690","DOI":"10.1172\/jci.insight.133690","article-title":"Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS","volume":"6","author":"Yu","year":"2021","journal-title":"JCI Insight"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1093\/ndt\/gfr754","article-title":"The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration","volume":"27","author":"Yu","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1681\/ASN.2015060704","article-title":"Low-energy shockwave therapy improves ischemic kidney microcirculation","volume":"27","author":"Zhang","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/ajh\/hpt207","article-title":"Silencing of HIF prolyl-hydroxylase 2 gene in the renal medulla attenuates salt-sensitive hypertension in Dahl S rats","volume":"27","author":"Zhu","year":"2014","journal-title":"Am. J. Hypertens."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1208105\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T12:08:59Z","timestamp":1687781339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1208105\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":48,"alternative-id":["10.3389\/fphys.2023.1208105"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2023.1208105","relation":{},"ISSN":["1664-042X"],"issn-type":[{"type":"electronic","value":"1664-042X"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"article-number":"1208105"}}